Introduction
Cytolytic T Iymphocytes (CTLs) of the CD8 subset recognize short peptides that are derived by processing from intracellular proteins and presented at the cell surface by major histocompatibility complex (MHC) class 1 molecules (Townsend et al., 1986b ; reviewed in Townsend and Bodmer, 1989) . External addition of synthetic peptides to cells has shown that MHC class I molecules can bind and present to CTLs of defined specificity not only one particular peptide but also aseries of analogs thereof that differ in length and antigenic potency. As opposed to this experience, naturally processed peptides retrieved from cells that synthesize the respective antigenic protein appear to be of rather limited diversity (Van Bleek and Nathenson, 1990; Rötzschke et al. , 1990a Rötzschke et al. , , 1990b . The underlying principles are not fully understood, although it seems clear that the MHC molecules themselves playa decisive role in endogenous peptide selection, because a peptide presented by a particular MHC class I molecule cannot be isolated from cells that do not express this MHC molecule (Falk et al., 1990) . Earlier steps in the generation of antigenic peptides involving cleavage of proteins by proteases are largely undefined (Yewdell and Bennink, 1990) .
There is ample evidence that processing and presentation of antigenic peptides are not dependent on the intracellular destination and the physiologic function ofthe antigenic protein (Townsend et al. , 1986a; Braciale et al., 1987; Volkmer et al. , 1987) . The antigenic sequence can even be part of a chimeric protein (Chimini et al. , 1989; Dei Val et al., 1991) . Until now the data were in accordance with the view that the sequence of the presented peptide is the only determinative parameter for its presentation. Based on this assumption, algorithms have been proposed for predicting antigenicityfrom sequence characteristics (DeLisi and Berzofsky, 1985; Rothbard and Taylor, 1987) . Yet now the predictive value of these algorithms has proven to be limited. An influence on antigen processing and presentation of residues that flank the finally presented antigenic peptide in the protein would explain failures of antigenicity predictions. We have therefore tested whether the amino acids that flank a sequence of defined antigenic potency have an effect on its processing and presentation. For this purpose we used the nonapeptide sequence 168YPHFMP_ TNL 176 (one-Ietter code), which is presented by the murine MHCclass I molecule Ld (Del Val et al. , 1988 Reddehase et al., 1989) and represents for CTLs of the BALBtc strain the only antigenic site recognized in the IE1 protein pp89 (Volkmer et al., 1987; Dei Val et al. , 1991) , a regulatory protein of murine cytomegalovirus (MCMV) (Keil et al. , 1987) . CD8 T Iymphocytes specific for that protein protect against lethai MCMV infection (Jonji6 et al., 1988) , and protective immunity is also induced by chimeric proteins that contain only the nonapeptide of pp89 as insert (Dei Val et al., 1991) . By placing this sequence into different positions of an unrelated carrier protein, we tested a possible position al effect on antigen presentation and used protection of mice against lethai virus challenge as a means to estimate its biological relevance.
Two findings are described. First, amino acids that flank an antigenic sequence in the protein can have a profound positive or negative effect on antigen processing and presentation, both in cell culture and in vivo. Second, differences in presentation efficiency reflected differences in the amount of naturally processed peptide.
Results
The Position within a Protein Is Determinative for Presentation of an Antigenic Sequence If antigen processing is governed only by the antigenic sequence itself, then presentation of a peptide of defined antigenic potency by the restricting MHC molecule should be independent of its location in the antigenic protein from wh ich it is derived by endogenous processing. To test this prediction, chimeric genes were constructed that contained the coding sequence for the antigenic nonapeptide '68YPHFMPTNL'76 at different positions of the hepatitis B virus core antigen (HBcAg) gene. This peptide was identified previously as the optimal antigenic peptide presented by the MHC class I molecule L d to clonal (Reddehase et Penta-alanine nanking is indicated. Asterisks mark Ihe chimeric proteins described preyiously (Dei Val et al. , 1991). al., 1989) as weil as polyclonal (Dei Val et al. , 1991) CTLs specific for the IE1 protein pp89 of MCMV. The chimeric genes were recombined into the genome of vaccinia virus. In Figure 1 A the constructs are represented schematically, and in Figure 1 B the sequences are listed. In one approach ( Figure 1A , top), the nonapeptide sequence (from now on referred to as 9-mer) and an 18-mer, comprising the 9-mer with authentie flan king residues, were translocated from their natural position within pp89 to a position close to the C-terminus. This was accomplished by inserting these sequences into amino acid position 553 of mutant ßF of pp89, in which the antigenie region is deleted from position 136-249 . Presentation occurred from ßF/9-mer (Dei Val et al. , 1991) and ßF/18-mer (Figures 3A and 3B, respectively) with no apparent difference to the presentation from authentie pp89 expressed in cells infected with the recombinant MCMV-iel-VAC (Volkmer et al., 1987) (Figure 3A ). In another approach (Figure 1 A, bottom) , the two peptide sequences were inserted into an unrelated carrier protein , HBcAg, either close to the C-terminus at position 179 (HBc/C-end/9-mer and HBc/C-end/18-mer) or close to the N-terminus at position 3 (HBc/N-end/9-mer and HBc/ N-end/18-mer). While presentation occurred from both 18-mer constructs ( Figure 3B ), a striking difference was seen for the two 9-mer constructs in that C-terminal integration was permissive for presentation of the inserted antigenie sequence, whereas N-terminal integration was unfavorable ( Figure 3A) .
The overall amount of chimeric protein synthesized in cells after infection with the vaccinia recombinants was controlled by Western blot and was found to be comparable in all cases considered (Figure 2) , and, specifically, also for construct HBc/N-end/9-mer (Iane g). Shifts in electrophoretic mObility of the chimeric proteins in relation to the carrier proteins chiefly correlated with the number of inserted amino acids , except that proteins containing insertions at the C-terminus had a slightly higher mObil ity than those with insertions at the N-terminus (Figure 2A , compare lanes c and e with lanes d and g, respectively) . This might be due to an altered phosphorylation at a C-terminal position of HBcAg close to the integration site (Ganem and Varmus, 1987) . In conclusion, the low efficiency of antigen presentation from HBc/N-end/9-mer cannot be explained by a reduced amount of protein available for processing .
To preclude any effect imposed by the vaccinia virus vector system , such as that studied by Townsend et al. (1988) , L1Ld cells were transfected with plasmids encoding the chimeric proteins HBc/N-end/18-mer and HBc/N-end/ 9-mer. Again, N-terminallocation of the 9-mer resulted in poor antigenicity ( Figure 3C ), which clearlyindicates that this integration site is unfavorable for presentation of the 9-mer, irrespective of the vector system employed. Collectively, these findings thus provided an example of a positional effect in antigenic peptide processing and presentation.
Proximity to the N-Terminus Does Not Account tor Poor Antigenicity
An apparent difference between HBc/N-end/18-mer and HBc/N-end/9-mer is the distance between the N-terminal methionine of the carrier protein and the first residue of the 9-mer, which is a tyrosine (Figure 1 B) . If the mere proximity of the N-terminus to the core of the antigenic sequence were incompatible with efficient antigen presentation, for any reason whatsoever, any means of spacing should restore antigenicity. We chose the following approach to the problem: the hepatitis B virus precore protein differs from HBcAg byan additional N-terminal sequence of 29 amino acids, the pre-C region (Ganem and Varmus, 1987) , which functions as a signal for secretion and mediates the translocation of the precore protein ac ross the membranes of the endoplasmic reticulum. By removal of the 19 N-terminal pre-C amino acids, and of a portion ofthe C-terminus, the precore protein is converted into HBeAg, wh ich is then actively secreted (Ou et al., 1986) . Thus, the 9-mer, when cloned into hepatitis B virus precore protein, is flanked by 10 additional N-terminal residues in the resulting chimeric HBeAg. As a consequence of the N-terminal insertion, chimeric proteins with lower electrophoretic mObility than expected from the number of inserted amino acids were accumulated and secreted ( correct removal of the C-terminal portion of HBeAg. The finding that presentation to CTLs of the antigenic sequence was equally poor from HBe/N-end/9-mer and HBc/ N-end/9-mer ( Figure 4A ) argues against a critical influence of the distance to the N-terminus of the carrier protein. It should be noted that here and in further experiments HBeand HBc-based constructs proved to be fully interchangeable. This finding is in accordance with previous experience that antigen processing is not dependent on the intracellular destination of the antigenic protein (Townsend et al., 1986a; Braciale et al., 1987; Volkmer et al., 1987) .
Oligo-Alanine Spacing Can Avoid Untavorable Flanking and Restores Presentation
At this stage, an influence of the linker and carrier protein sequences directly flanking the antigenic insert (see Figure 1 B) appeared to us the most likely explanation for the observed positional effect on antigen presentation. If this were true, creation of a permissive flanking by proper substitutions should be possible. Instead of performing numerous trial and error substitutions, we preferred another approach: it was known from previous experience with synthetic peptides that flanking of the 9-mer with alanines leaves its antigenic potency essentially unchanged (data not shown). Flanking with alanines could therefore serve to space the antigenic sequence from unfavorable neighboring residues. In accordance with previous data (Dei Val et al., 1991) , penta-alanine flanking in HBc/C-end/A s 9-merAs did not disturb presentation from a permissive site ( Figure 4B ). Yet, remarkably, penta-alanine flanking in HBe/N-end/As9-merAs converted the N-terminal site from an unfavorable into a favorable site for antigen processing and presentation ( Figure 4C ). Earlier work has shown that the heptapeptide sequence '69PHFMPTN '75 is not presented from intracellularly synthesized pp89-t1F-or HBc-based chimeric proteins (Dei Val et al., 1991) even though this peptide (Reddehase et al. , 1989) and the alanine-flanked analog APHFMPTNA are antigenic when externally added to L d-expressing cells. We therefore wondered whether the strategy of oligo-alanine spacing would also help the heptapeptide sequence to get presented. This was not the case ( Figure 40 ). The affinity of the heptapeptide to L dis at least two orders of magnitude lower than that of the 9-mer , and, since alanine flanking does not increase the affinity, we speculate that in this case not the flan king residues but the low affinity to L d of the antigenic sequence itself is responsible for the failure in presentation.
In conclusion, oligo-alanine spacing cannot overcome insufficient antigenicity of a peptide sequence, but it can help avoid negative influences of neighboring residues on an optimal antigenic sequence.
The Efficiency of Antigen Presentation Is Critical for the Induction of Protective Immunity
Thus far, the simian virus 40-transformed ceilline BALB.SV was used for studying antigen presentation, and, there- ---fore, one could argue that the data have characterized the processing and presentation properties of this particular ceilline rather than having described a principle. No single cell line can apriori be considered representative of the cells that process the chimeric proteins in vivo. It has been shown in previous re ports that protection induced by pp89 or the 9-mer thereof is mediated solely by T Iymphocytes of the CD8 subset (Jonji6 et al., 1988; Dei Val et al., 1991) . Therefore, an unambiguous way to test the in vive relevance of the in vitro findings was to probe the quality of the various recombinants in protecting against lethai MCMV infection ( Figure 5 ). In accordance with previous work (Dei Val et al. , 1991) , the 9-mer, when integrated at the C-terminus of HBcAg in the construct HBc/C-end/9-mer, was sufficient to induce significant protective immunity. The two 18-mer constructs induced a similar degree of protection, whereas N-terminal integration of the 9-mer in HBc/N-endl 9-mer failed in protection. Induction of pp89-specific T Iymphocytes with the laUer recombinant could only be detected after selective secondary restimulation in vitro (data not shown). Finally, as was the case with target cell formation, penta-alanine flan king in HBe/N-end/A s 9-merA s successfully restored also the protective capacity in vivo. In conclusion, the differences in antigen presentation efficiencies as seen in vitro in terms of target cell formation for recognition by CTLs are directly reflected by the quality of the respective recombinants to induce protective CD8 T Iymphocytes, wh ich demonstrates that antigen processing and presentation follow the same rules in the cell types that are relevant in vivo.
Differences in Antigen Presentation Efficiency Can not Be Explained by Differences in the Overall Stability of the Chimeric Proteins
In vaccinia virus-infected cells, antigen presentation can be improved by increasing the overall degradation rate of antigenic proteins (Townsend et al., 1988) . We therefore studied whether poor presentation from the construct HBcl N-end/9-mer was associated with high stability of the respective chimeric protein. merA s was not accompanied by an increased protein degradation rate (Figure 6 , [f) and [g)). It was therefore concluded that the overall stability of the chimeric proteins did not account for the differences in efficiency of antigen presentation observed in vitro as weil as in vivo.
Processing from an Unfavorable Site Leads to a Lower Amount of Naturally Processed Peptide
What is the molecular explanation for the observed differences in target cell formation and in vive T Iymphocyte sensitization? Antigen presentation requires that the antigenie protein is properly cleaved so as to not destroy the antigenic site and to generate peptide(s) that can bind to the presenting MHC molecules. If natural processing generates peptides that are longer than the inserted optimal antigenic sequence, then processing from the various chimeric proteins, all of which provide their individual flanking residues (see Figure 1 B) , would lead to different peptides that are likely to differ in their binding affinity for Ld and will thus be presented with different efficiency. Accordingly, reduced antigen presentation from an unfavorable site can have two reasons: processing could generate a lower amount of the optimal antigenic peptide, or could generate longer, suboptimal peptide(s).
The recently described method of extracting naturally processed peptides from cells (Rötzschke et al. , 1990b) should give the information whether after processing of the chimeric proteins the same peptide or different peptides can be recovered. Naturally processed peptides were acid extracted from infected cells and analyzed by reverse-phase high pressure liquid chromatography (HPLC). As a reference, the optimal synthetic nonapeptide was also subjected to HPLC and was found to elute in an acetonitrile gradient as one dominant peak of biological activity ( Figure 7A ), corresponding to the only peak detected spectrophotometrically (data not shown). Also indicated in Figure 7 Aare the elution properties of a relevant set of related peptides of different lengths, none of which coeluted with the nonapeptide. The activity of naturally processed peptides extracted from cells infected with MCMV-iel-VAC, encoding authentic pp89, and the vaccinia recombinant HBc/C-end/9-mer, containing the 9-mer at a permissive site ofthe unrelated carrier protein HBcAg, was of comparable intensity and coeluted in both cases with the synthetic nonapeptide in fraction 25 ( Figures 7B  and 7C, respectively) . Notably, insertion into the unfavorable site in HBc/N-end/9-mer resulted in a lower activity, yet again, in the same fraction (Figure 70 ), and rescue of presentation by penta-alanine flan king in HBe/N-end/ As9-merAs restored the activity retrieved from the cells ( Figure 7E ).
Based on the identity of the elution characteristics, it appeared to us reasonable to assume that biological activity relates directly to the amount of extracted peptide. On this premise, processing from the unfavorable construct H Bc/N-end/9-mer was quantitated and compared with processing from the rescue construct HBe/N-end/A s 9-merA s and from the favorable construct HBc/C-end/9-mer, by diluting fraction 25 of the respective HPLC runs before the cytolytic assay. The difference in cell number needed for peptide extraction to get at comparable activity was about 16-fold between the poorly presented and the two efficiently presented chimeric proteins (Figure 8 ).
In conclusion, inefficient antigen presentation can be explained by the generation of a lower amount of naturally processed peptide.
Discussion
Insertion of a nonapeptide sequence of defined antigenicity into different positions of an unrelated carrier protein has demonstrated a critieal role of flan king residues in determining the efficiency of antigen processing and presentation. This finding has important implications for the predictability of antigenic sites in proteins, for the design of recombinant vaccines, and for the understanding of principles that govern antigen processing and peptide presentation.
From the compilation of amino acid sequences of empirically identified antigenic peptides, algorithms have been formulated to predict antigenic sequences recognized by T Iymphocytes. These algorithms are being used to screen protein sequences for certain motifs. Motifs indicate the propensity of a peptide to adopt a particular sterical configuration (DeLisi and Berzofsky, 1985) or represent a pattern of residues with a typical polarity distribution (Rothbard and Taylor, 1987 ). Yet, even though successfully employed in some cases, these algorithms have been of limited predictive value. This does not imply that the al gorithms are wrong, but may indicate that other parameters in addition to the sequence of an antigenic peptide are critically involved in its generation and presentation. An immediate idea for explaining the failures of antigenicity predictions is that different allelic MHC moleeules show subtle preferences for structural features of peptides that cannot be included in a general prediction model. Yet, if this were the only reason, then a peptide with defined affinity for a particular presenting MHC class I molecule should always be presented regardless of the position in the protein from which it is derived by processing. Our results show that this is not the case. Of the two positions chosen at random in the unrelated carrier protein HBcAg, one was permissive for processing and presentation of the antigenic nonapeptide insert, whereas the other was unfavorable. This finding unambiguously documents that proven antigenicity of an amino acid sequence is no guarantee for its adequate processing in the cell. Thus, in the cases of failure, prediction algorithms may have correctly predicted a potentially antigenic sequence, which, however, remained nonantigenic and consequently invisible in assays because an unfavorable position in the protein precluded the generation of the respective peptide.
The finding that residues that flank an antigenic insert have a critical influence on its proper processing complicates the design of recombinant vaccines. One either has to test several insertion sites by trial and error or to learn the rules that make flan king residues permissive or nonpermissive, which may be cumbersome as the role of flanking residues may depend on the sequence of the insert. A sort of "neutral spacing" to separate the insert from disadvantageous influences of its neighboring residues could be an easier solution to the problem. In our example, unfavorable insertion was overcome by penta-alanine flan king of the antigenie insert. Systematic analysis will have to define whether or not oligo-alanine flan king is generally applicable, that is, for other antigenic sequences, other carrier proteins, and other presenting MHC molecules.
Wh ich are the peptides generated by natural processing? Are they different for the different chimeric proteins, or is the antigenie insert itself retrieved in all cases? The main biological activity extracted from cells infected with four different recombinants eluted in all four cases in the same fraction and, moreover, coeluted with the synthetic nonapeptide. If peptides longer than the 9-mer were generated by natural processing from the chimeric proteins, they all should differ from each other, because in all of them the 9-mer insert is provided with essentially different flankings (see Figure 1 B ). In accordance with others (Rötzschke et al., 1990a) we have had the experience that longer or shorter peptides elute in different fractions. This was true for the 18-mer and 7-mer, for two octapeptides, and even for the two decapeptides in wh ich the nonapeptide is flanked on one side by only one authentic residue. Even though one cannot exclude the possibility that, by chance, two different peptides coelute, the probability that four different longer peptides from the four recombinants all coelute with the nonapeptide is very low. This strongly argues against longer peptides being the finally presented ones.
The idea that peptides shorter than the 9-mer are presented can also be refuted, because the 7-mer, wh ich is the most antigenic peptide among the shorter analogs , not only eluted as synthetic peptide in a different fraction, but also was not presented from chimeric proteins in which it constituted the insert. The mullitude of proteins synthesized in the vaccinia virus expression system precluded the approach of natural peptide sequencing employed by Van Bleek and Nathenson (1990) , but the evidence is close to proof that the inserted nonapeptide is, in fact, the dominant natural antigenic peptide. In light of recent emphasis given to an observed discrepancy between a synthetic peptide and the corresponding naturally processed peptide (Rötzschke et al., 1990a) , the concordance seen in our case was not apriori predictable. The example shows that a discrepaney between natural peptides and predietions obtained with synthetic peptides cannot be taken for a prineiple. We rather think that accurate definition of the optimal peptide by systematic biterminal shortening of an antigenic sequenee (Reddehase et al. , 1989) can correetly predict the naturally processed peptide. It is also worth mentioning that the few other natural peptides described so far (Van Bleek and Nathenson, 1990; Rötzschke et al., 1990a; Falk et al. , 1991) are also nona-or octapeptides.
How do flanking residues influence the efficiency of endogenous processing and what can our example contribute to the understanding of the still unknown processes of antigenie peptide generation and presentation? The current opinion is that antigen processing and presentation include at least four steps: first, partial degradation of the antigenie protein, supposedly in the cytosol; second, transport of peptides into the endoplasmic reticulum; third, loading of MHC class I moleeules to form a trimolecular complex of MHC class I heavy chain, peptide, and ß2-microglobulin; and, fourth, transport of the complex to the cell surface (Yewdell and Bennink, 1990; Parham, 1990; . Poor presentation from the unfavorable integration site in HBc/N-end/9-mer was found to be associated with a low amount of recoverable antigenie peptide. We see four possibilities for explanation. First, the reduced amount could result already from an inefficient overall protein cleavage as in the example given by Townsend et al. (1988) . In the case reported here, insertions in HBcAg led to slightly different stability of the chimeric proteins, but there was no correlation between protein stability and amount of naturally processed peptide.
Second, the type of residues flanking the antigenie sequence may codetermine the local protein conformation atthe antigenie site, and thereby affectthe local accessibility for proteases, or may directly account for the presence or absence of cleavage signals for proteases. In both instances, flan king can be favorable or unfavorable for the efficient release of the correct and intact antigenie sequence from the protein. A putative conformational effect on local cleavage efficiency is difficult to prove or refute, and from our examples of efficient presentation from chimeric proteins we do not recognize a consensus in the flan king sequences that could promote cleavage. Future tests will have to show which of the flan king residues, alone or in combination, are responsible for the poor presentation from HBc/N-end/9-mer. One could consider, for instance, the two-sided flanking byglycines and negatively charged residues, as is the case in this construct.
The third possibility to explain poor presentation is that the recently discussed peptide transporters (Parham, 1990) might select peptides by unknown criteria.
The fourth possibility is that longer peptides are excised from the protein in the first place, get transported, associate with Ld, and are then trimmed to the finally presented peptide, a mechanism discussed as one possibility to explain how MHC class I moleeules select and protect peptides from complete degradation (Falk et al., 1990) . That MHC class I moleeules playa decisive role in peptide selection is based on the finding that a particular antigenie peptide can only be extracted from cells that express the corresponding presenting MHC moleeule (Falk et al. , 1990) . The same is true for the peptide derived from pp89, since no biological activity was recovered from infected cells of the mutant mouse strain BALB/c-H-2 dm2 , in wh ich the Ld gene is deleted (unpublished data). According to this mechanism, longer peptides, in which flanking residues modulate the binding affinity to Ld, will be protected to different degrees from degradation. The bound fraction is then trimmed, thereby yielding different amounts of only one dominant peptide from the various chimeric proteins.
In conclusion, residues that directly flank the antigenie sequence in a protein critically influence the amount of naturally processed and presented antigenie peptide. The demonstration that the degree of protection against lethai disease achieved with the recombinants relates directly to the amount of correctly processed peptide underlines the importance of the findings.
Experimental Procedures
Mice BALB/c mice (H-2" haplotype) were bred in our colony under specific pathogen-Iree conditions. Cells BALB.SV, a continuously growing libroblast ceilline, was isolated Irom primary cultures 01 BALB/c mouse embryo libroblasts that were inlected with wild-type simian virus 40.
Recombinant Vaccinia Vlruses
The recombinant vaccinia virus MCMV-ie/-VAC encodes pp89 (Volkmer et al. , 1987) . The recombinant MCMV-ie/(t>F)-VAC, also referred to as t>F, encodes a deletion mutant 01 pp89 that lacks amino acids 136-249 and therelore does not contain any epitope recognized by BALB/c CTLs (Dei . Insertion of pp89 Antigenic Sequences into Hepatitis B Virus Genes An HBcAg gene was used, the 5' end of which is derived Irom a synthetic gene (Nassal, 1988) and therelore contains a Clal site 1 codon downstream 01 the HBcAg initiation codon. This restrietion site was used lor the insertion 01 synthetic oligonucleotides encoding pp89 antigenic sequences. For insertions in the HBeAg gene (Ganem and Varmus, 1987) , the same restrietion site was used. In addition, the initial AUG codon for HBcAg was converted into AUA by site-directed mutagenesis, in order to prevent translation initiation at this position (Schlicht and Schaller, 1989) . For insertions atthe 3' end ofthe HBcAg gene, a natural Aval site located 5 codons upstream 01 the termination codon was used. All constructs were conlirmed by sequencing belore their recombination into vaccinia virus, under the control 01 the earlylate P7.5K promoter, as described (Volkmer et al., 1987) . Insertion of pp89 Antigenic Sequences into Deletion Mutant t>F To reintegrate pp89 sequences at a different position 01 pp89, deletion mutant t>F was chosen. A unique Bglli site in the 3' end 01 the t>F reading Irame (Keil et al. , 1987; Dei Val et al., 1988) , at codon number 553, was used as insertion si te lor synthetic oligonucleotides. All constructs were sequenced and then recombined into vaccinia virus.
Expression olthe chimeric proteins in cells inlected with the vaccinia recombinant viruses was tested by Western blot as described (Dei Val et al., 1991) . Transfection UL" cells, which are derived !rom mice 01 H-2' haplotype and were translected with the gene lor the MHC class I molecule L" (Ponta et al. , 1985) , were supertransfected with plasmids encoding the chimeric protein HBc/N-endI18-mer or HBc/N-end/9-mer under the control 01 the metallothionein promoter (Junker et al.. 1987) . For selection 01 translected colonies, a plasmid carrying the gene lor neomycin resistance was cotransfected (Colbere-Garapin et al., 1981) .
Synthetic Peptides and Ollgonucleotides Peptides were synthesized in an Applied Biosystems peptide synthesizer model 431A and analyzed by reverse-phase HPLC. Oligonucleotides were synthesized in an Applied Biosystems oligonucleotide synthesizer model 381A.
Cytolytic Assays BALB.SV cells were used for infection with recombinant vaccinia viruses to produce target cells as described . pp89-specific CTLs were generated by in vitro restimulation with purified MCMV of spleen cells from mice that had been infected with MCMVie/-VAC and were used as effector cells in a standard 3 hr cytolytic assay . Graded numbers of cytolytic effector cells in 2-fold or 3-fold dilution steps were used. Data represent the mean percentage of specific lysis from three replicate cultures.
Pulse-Chase Analysis BALB.SV cells (5 x 10 6 ) were labeled for 30 min with 0.5 mCi of I"'S]methionine (1200 Ci/mmol) in methionine-free medium 8 hr after infection with recombinant vaccinia viruses. Incorporation was term inated by the addition of nonradioactive methionine to a final concentration of 0.45 mM. Cells were then chased for 0, 1, and 4 hr in normal culture medium. At each chase time, sam pies were taken and subjected to two rounds of immunoprecipitation with an antiserum recognizing both HBcAg and HBeAg (Schlicht, 1991) .
Isolation of Naturally Processed Peptides BALB.SV cells were infected in parallel with all mentioned recombinant vaccinia viruses at a multiplicity of infection of 3 pfu per cell, and 20 hr later, naturally processed peptides were extracted in parallel from whole cells with trifluoroacetic acid as described (Rötzschke et al. , 1990b) . Briefly, trifluoroacetic acid-soluble material was separated first on a Sephadex G25 column and sUbsequentlyon an HPLC reverse-phase column. Lyophilized fractions were resuspended, diluted in RPMI 1640 culture medium, and dispensed into microtiter plates. 51Cr-labeled BALB.SV cells were then added and, after 1 hr of incubation, pp89-specific cytolytic effector cells were added for a standard 3 hr cytolytic assay. Naturally processed peptides from cells infected with all recombinant viruses were tested in parallel.
Protection In Vlvo Mice were immunized i.v. with 1 x 10" pfu of recombinant vaccinia viruses and challenged i.p. 3 weeks later with 3 LDsos of MCMV, strain Smith (VR-194; American Type Culture Collection, Rockville, MD), isolated from the salivary glands of infected mice .
